Vaginal micronized progesterone versus the levonorgestrel‐releasing intrauterine system for treatment of non‐atypical endometrial hyperplasia: A randomized controlled trial
Vaginal micronized progesterone and the levonorgestrel-releasing intrauterine system demonstrated similar regression rates for non-atypical endometrial hyperplasia, with progesterone showing a slight advantage in reducing perceived blood loss.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study via openalex
- Effectiveness of bipolar impedance controlled radiofrequency (NovaSure) endometrial ablation for the treatment of menorrhagia in Hong Kong Chinese women via openalex
- Levonorgestrel-Releasing Intrauterine Device Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia via openalex
- The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women via openalex
- The Efficacy of Dienogest in the Treatment of Simple Endometrial Hyperplasia without Atypia via openalex
- doi:10.1002/14651858.cd012658.pub2 via openalex
- doi:10.3109/13697137.2010.490605 via openalex
- doi:10.1093/humrep/15.suppl_1.149 via openalex
- doi:10.1080/13697137.2016.1187123 via openalex
- doi:10.1097/igc.0000000000000927 via openalex
- doi:10.1016/0378-5122(94)90016-7 via openalex
- doi:10.1111/1471-0528.12499 via openalex
- doi:10.1080/09513590410001692519 via openalex
- doi:10.1185/03007995.2010.532200 via openalex
- doi:10.1007/s00404-019-05299-2 via openalex
- doi:10.1097/01.ogx.0000795856.43401.5a via openalex
- doi:10.1016/j.ygyno.2003.07.002 via openalex
- doi:10.1159/000321390 via openalex
- doi:10.1111/j.1525-1438.2006.00533.x via openalex
- doi:10.1007/s00404-014-3161-4 via openalex
- doi:10.3109/09513590.2014.945904 via openalex
- doi:10.1177/1933719112459243 via openalex
- doi:10.1016/j.ajog.2010.07.037 via openalex
Cited by (2)
- The efficacy of levonorgestrel intrauterine device, medroxyprogesterone acetate, and norethisterone acetate in the treatment of endometrial hyperplasia without atypia 2024
- Efficacy of drugs treatment in patients with endometrial hyperplasia with or without atypia: A systematic review and network meta-analysis 2024
Source provenance
- openalex
- last seen: 2026-05-13T19:19:07.993179+00:00